2023-07-28 03:48:13 ET
- Chemours press release ( NYSE: CC ): Q2 Non-GAAP EPS of $1.10 beats by $0.03 .
- Revenue of $1.64B (-14.6% Y/Y) misses by $50M .
- Adjusted EBITDA of $324 million and Free Cash Flow of $3 million.
- Outlook: The Company is updating its full year 2023 Adjusted EBITDA guidance. The Company now expects full year 2023 Adjusted EBITDA to be within the range of $1.100 to $1.175 billion and Free Cash Flow of greater than $325 million, inclusive of approximately $400 million of capital expenditures which remains unchanged.
For further details see:
Chemours reports mixed Q2 earnings; updates FY23 outlook